PHIO — Phio Pharmaceuticals Corp.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1533040 ·
Last close
$1.02
Market Cap
$11.91M
52W High
$1.22
52W Low
$0.84
ADV30
1,111,896
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -4,167,000 | -4,003,000 | 17,412,000 | 17,031,000 | 950,000 |
| Dec 2025 | 0 | — | -2,534,000 | -2,371,000 | 21,487,000 | 21,031,000 | 1,340,000 |
| Sep 2025 | 0 | — | -2,505,000 | -2,392,000 | 11,505,000 | 10,705,000 | 1,666,000 |
| Jun 2025 | 0 | — | -2,309,000 | -2,166,000 | 11,301,000 | 10,775,000 | 1,206,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,979,000
Investing CF
$-12,000
Financing CF
$23,640,000
CapEx
$-12,000
Dividends Paid
—
Buybacks
$-1,000
EPS Diluted TTM
$-2.84
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-155,054,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-9,220,000
Pretax Income TTM
$-8,698,000
Interest Exp TTM
—
Analysts
1
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -9,220,000 | -8,698,000 | 21,487,000 | 1,340,000 | — | -7,979,000 |
| Dec 2024 | 0 | -7,387,000 | -7,150,000 | 5,738,000 | 1,015,000 | — | -7,112,000 |
| Dec 2023 | 0 | -10,698,000 | -10,826,000 | 9,364,000 | 1,634,000 | — | -10,749,000 |
| Dec 2022 | 0 | -11,462,000 | -11,480,000 | 12,814,000 | 1,976,000 | — | -12,129,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.86
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PBM | PSYENCE BIOMEDICAL LTD. | $12.09M | $3.17 | — |
| BLRX | BioLineRx Ltd. | $12.27M | $2.82 | — |
| BIVI | BIOVIE INC. | $11.46M | $1.52 | — |
| CMMB | Chemomab Therapeutics Ltd. | $11.36M | $1.55 | — |
| KPRX | KIORA PHARMACEUTICALS INC | $11.35M | $2.56 | — |
News headlines (Yahoo Finance, 1h cache)
Correction to Announcement Regarding Phio Pharmaceuticals Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
2026-07-22 16:30 · Yahoo
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
2026-07-22 11:00 · Yahoo
Phio Pharmaceuticals Announces Appointment of Dr. R. Todd Plott to the Board of Directors
2026-07-21 11:00 · Yahoo
Phio Pharmaceuticals Expands Global Patent Portfolio With New International Patent Milestones
2026-07-15 15:06 · Yahoo
Phio Pharmaceuticals Announces Patent Milestone with Multiple Notices of Allowance and Grant Decision
2026-07-15 11:00 · Yahoo
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
2026-06-26 12:35 · Yahoo
Phio Pharmaceuticals Announces "How siRNA Therapy can Change the Course of Cancer Treatment" in a Fireside Chat with Force Family Office on Monday, June 29, 2026
2026-06-25 11:00 · Yahoo
Phio Pharmaceuticals Reaches Key Milestone in Advancing Lead Candidate PH-762
2026-06-24 11:00 · Yahoo
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
2026-06-23 12:35 · Yahoo
Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026
2026-06-18 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.